Kim C. Coley

Dr. Kim C. Coley

University of Pittsburgh
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2002 in Journal of Clinical Anesthesia
Verified
Journal Article
Closed access
Kim C. ColeyKim C. Coley
Kim C. Coley
BWBrian A Williams
Brian A Williams
SDStacey V DaPos
Stacey V DaPos
CCConnie Chen
Connie Chen
RSRandall B Smith
Randall B Smith

1 December 2003 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
PLPeter K. Linden
Peter K. Linden
SKShimon Kusne
Shimon Kusne
Kim C. ColeyKim C. Coley
Kim C. Coley
PFPaulo Fontes
Paulo Fontes
DKDavid J. Kramer
David J. Kramer
DPDavid L Paterson
David L Paterson
Serious infection due to strains of Pseudomonas aeruginosa that exhibit resistance to all common antipseudomonal antimicrobials increasingly is a ser

1 July 2020 in JAMA Network Open
Verified
Journal Article
Closed access
PDF file
LBLucas A. Berenbrok
Lucas A. Berenbrok
NGNico Gabriel
Nico Gabriel
Kim C. ColeyKim C. Coley
Kim C. Coley
IHInmaculada Hernandez
Inmaculada Hernandez
The shift toward value-based care has placed emphasis on preventive care and chronic disease management services delivered by multidisciplinary health care teams. However, some patients continue to have difficulty accessing affordable quality care. Pharmacists are accessible and trusted members of the health care team and routinely encounter patients at their community pharmacies. Patient-pharmacist encounters have traditionally focused on the provision of medications. More recently, community pharmacists have transformed and optimized their roles from product-centered services (ie, medication dispensing and sale of over-the-counter medications) to patient-centered services (ie, medication therapy management). The goal of medication therapy management is to optimize medication use, reduce the risk of adverse events, and improve medication adherence.1

1 February 2008 in The Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
KBKristin L. Bigos
Kristin L. Bigos
BPBruce G. Pollock
Bruce G. Pollock
Kim C. ColeyKim C. Coley
Kim C. Coley
DMDel D. Miller
Del D. Miller
SMStephen R. Marder
Stephen R. Marder
RBRobert R. Bies
Robert R. Bies

1 March 2004 in Anesthesiology
Verified
Journal Article
Closed access
BWBrian A. Williams
Brian A. Williams
MKMichael L. Kentor
Michael L. Kentor
MVMolly T. Vogt
Molly T. Vogt
WVWilliam B. Vogt
William B. Vogt
Kim C. ColeyKim C. Coley
Kim C. Coley
FFFreddie H. Fu
Freddie H. Fu
Background: Anterior cruciate ligament reconstruction is a complex outpatient surgical procedure often associated with pain. Traditionally, the procedure is performed under general anesthesia and often requires the use of the PACU. Refractory pain and/or nausea/vomiting occasionally leads to an unplanned hospital admission. In this study, the authors examine the associations of nerve block analgesia for these patients and its associated reductions in PACU use, hospital admission, and hospital costs. Methods: This was an observational, nonrandomized study in which existing data regarding patients' day-of-surgery outcomes were merged with hospital cost data. We reviewed a consecutive sample of 948 men and women who were in good health and underwent anterior cruciate ligament reconstruction in an outpatient surgery unit between July 1995 and June 1999. Results: The use of nerve block analgesia was associated with reduced PACU admissions to 18% and decreased unplanned hospital admission rates from 17% to 4%. Multivariate linear regression analysis showed that patients bypassing the PACU had an associated hospital cost reduction of 12% (P = 0.0001), whereas patients who needed hospital admission had an associated hospital cost increase of 11% (P = 0.0003). Conclusions: The use of nerve blocks for acute pain management in patients undergoing anterior cruciate ligament reconstruction is associated with PACU bypass and reliable same-day discharge. Although the cost savings for this one procedure are unlikely to generate sufficient cost savings via staffing reductions, extrapolating these results to a large volume of all types of invasive outpatient orthopedic procedures may have the potential to create significant hospital cost savings.

1 August 2010 in American Journal of Health-System Pharmacy
Verified
Journal Article
Closed access
PDF file
SLStacey M. Lavsa
Stacey M. Lavsa
TFTanya J. Fabian
Tanya J. Fabian
MSMelissa I. Saul
Melissa I. Saul
SCShelby L. Corman
Shelby L. Corman
Kim C. ColeyKim C. Coley
Kim C. Coley
Purpose The influence of medications and diagnoses on fall risk in psychiatric inpatients was evaluated. Methods In this retrospective case–control study, psychiatric inpatients age 18 years or older with a documented fall that was reported served as study cases. These patients were matched to control patients from the same hospital (1:1) by admission year, sex, and age. Psychiatric diagnoses evaluated included major depressive disorder, schizophrenia or schizoaffective disorder, bipolar disorder, Alzheimer’s disease and dementia, anxiety or neurosis, delirium, personality disorder, and obsessive-compulsive disorder. Medications assessed as independent variables were conventional antipsychotics, atypical antipsychotics, selective serotonin-reuptake inhibitors, tricyclic antidepressants, atypical antidepressants, monoamine oxidase inhibitors, lithium, anticonvulsants, benzodiazepines, nonbenzodiazepine sleep aids, Alzheimer’s disease medications, antihistamines, antiarrhythmics, antihypertensives, benign prostatic hyperplasia medications, oral hypoglycemic agents, histamine H2-receptor blockers, laxatives and stool softeners, muscle relaxants, nonsteroidal antiinflammatory drugs, opioids, Parkinson’s disease medications, and overactive bladder medications. Univariate logistic regression models were developed for each risk factor to determine its impact on fall risk. Results A total of 774 patient cases were matched with controls. Most falls occurred on the second day of hospitalization. Medications associated with a higher risk of falls were α-blockers, nonbenzodiazepine sleep aids, benzodiazepines, H2-blockers, lithium, antipsychotics, atypical antidepressants, anticonvulsants, and laxatives and stool softeners. Patients with a diagnosis of dementia and Alzheimer’s disease also had an increased risk of falling. Conclusion Alpha-blockers, nonbenzodiazepine sleep aids, benzodiazepines, H2-blockers, lithium, atypical antipsychotics, atypical antidepressants, anticonvulsants and mood stabilizers, conventional anti-psychotics, laxatives and stool softeners, and dementia and Alzheimer’s disease were significant predictors of inpatient falls in a psychiatric population.